GB201309085D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201309085D0
GB201309085D0 GB201309085A GB201309085A GB201309085D0 GB 201309085 D0 GB201309085 D0 GB 201309085D0 GB 201309085 A GB201309085 A GB 201309085A GB 201309085 A GB201309085 A GB 201309085A GB 201309085 D0 GB201309085 D0 GB 201309085D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201309085A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Redx Pharma Ltd
Original Assignee
Redx Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redx Pharma Ltd filed Critical Redx Pharma Ltd
Priority to GB201309085A priority Critical patent/GB201309085D0/en
Publication of GB201309085D0 publication Critical patent/GB201309085D0/en
Application status is Ceased legal-status Critical

Links

GB201309085A 2013-05-20 2013-05-20 Compounds Ceased GB201309085D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB201309085A GB201309085D0 (en) 2013-05-20 2013-05-20 Compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201309085A GB201309085D0 (en) 2013-05-20 2013-05-20 Compounds
PCT/GB2014/051542 WO2014188173A1 (en) 2013-05-20 2014-05-20 Pyrazolopyrimidine derivatives useful as inhibitors of bruton's tyrosine kinase

Publications (1)

Publication Number Publication Date
GB201309085D0 true GB201309085D0 (en) 2013-07-03

Family

ID=48747060

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201309085A Ceased GB201309085D0 (en) 2013-05-20 2013-05-20 Compounds

Country Status (2)

Country Link
GB (1) GB201309085D0 (en)
WO (1) WO2014188173A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201410430D0 (en) * 2014-06-11 2014-07-23 Redx Pharma Ltd Compounds
JP2018513205A (en) * 2015-02-12 2018-05-24 上▲海▼度▲徳▼医▲藥▼科技有限公司 Production method of ibrutinib
CN106146511A (en) * 2015-04-03 2016-11-23 安润医药科技(苏州)有限公司 Pyrazolopyrimidine derivative, preparation method, pharmaceutical composition and purposes
WO2016154998A1 (en) * 2015-04-03 2016-10-06 安润医药科技(苏州)有限公司 Pyrazolopyrimidine derivative, manufacturing method, pharmaceutical composition, and use thereof
CN104844609B (en) * 2015-05-12 2016-07-13 杭州和正医药有限公司 The irreversible bruton's tyrosine kinase inhibitor of dibit point
AU2016322063A1 (en) 2015-09-16 2018-04-12 Loxo Oncology, Inc. Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer
KR20180115261A (en) 2015-12-16 2018-10-22 록쏘 온콜로지, 인코포레이티드 Compound useful as a kinase inhibitor
SG11201805154YA (en) * 2015-12-23 2018-07-30 Arqule Inc Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
US9630968B1 (en) 2015-12-23 2017-04-25 Arqule, Inc. Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
CN106928231A (en) * 2015-12-31 2017-07-07 合肥中科普瑞昇生物医药科技有限公司 The kinase inhibitor of the new EGFR wild types of one class and saltant type
JP2019501930A (en) 2016-01-15 2019-01-24 ファイザー・インク 6,7,8,9-tetrahydro-5H-pyrido [2,3-d] azepine dopamine D3 ligand
WO2017133630A1 (en) * 2016-02-05 2017-08-10 北京盛诺基医药科技有限公司 Inhibitor of bruton's tyrosine kinase
CN105777759B (en) * 2016-04-29 2018-01-26 杭州和正医药有限公司 A kind of bruton's tyrosine kinase inhibitor
CN106146518A (en) * 2016-06-30 2016-11-23 苏州爱玛特生物科技有限公司 A kind of bruton's tyrosine kinase inhibitor intermediate and preparation method thereof
WO2018002958A1 (en) 2016-06-30 2018-01-04 Sun Pharma Advanced Research Company Limited Novel hydrazide containing compounds as btk inhibitors
CA3043376A1 (en) * 2016-11-15 2018-05-24 Hangzhou Hertz Pharmaceutical Co., Ltd. Selective bruton's tyrosine kinase inhibitor and use thereof
CN109369654A (en) * 2018-11-20 2019-02-22 山东大学 1,3- bis- substituted-4-amino Pyrazolopyrimidines and its preparation method and application

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201508035TA (en) 2007-03-28 2015-10-29 Pharmacyclics Inc Inhibitors of bruton's tyrosine kinase
PT2530083T (en) 2006-09-22 2016-08-01 Pharmacyclics Llc Inhibitors of bruton's tyrosine kinase
EP2089391B1 (en) 2006-11-03 2013-01-16 Pharmacyclics, Inc. Bruton's tyrosine kinase activity probe and method of using
DK2361248T3 (en) 2008-06-27 2019-01-14 Celgene Car Llc Heteroberl compounds and uses thereof
US8338439B2 (en) 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
US8426428B2 (en) 2008-12-05 2013-04-23 Principia Biopharma, Inc. EGFR kinase knockdown via electrophilically enhanced inhibitors
US7718662B1 (en) 2009-10-12 2010-05-18 Pharmacyclics, Inc. Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
JP5841998B2 (en) 2010-06-03 2016-01-13 ファーマサイクリックス,インク. Use of inhibitors of breton-type tyrosine kinase (Btk)
AU2012255759B2 (en) 2011-05-17 2017-08-10 Principia Biopharma, Inc. Kinase inhibitors
AU2012255860C1 (en) 2011-05-17 2015-12-10 Principia Biopharma Inc. Tyrosine kinase inhibitors
US9138436B2 (en) 2011-07-13 2015-09-22 Pharmacyclics Llc Inhibitors of Bruton's tyrosine kinase
US8377946B1 (en) * 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors

Also Published As

Publication number Publication date
WO2014188173A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
AU354395S (en) Case
GB201311001D0 (en) Lucabella
GB201413149D0 (en) No details
SG11201506514QA (en) Trk-INHIBITING COMPOUND
AU354443S (en) Case
GB201307577D0 (en) New compounds
AU355447S (en) Case
HK1222846A1 (en) Substituted benzylpyrazoles
GB201505425D0 (en) Not published
GB201309085D0 (en) Compounds
PL2953956T3 (en) Heteropolyoxometalates
HK1221717A1 (en) Substituted benzylpyrazoles
GB201311888D0 (en) Novel compounds
EP2989885A4 (en) Combine
IL240903D0 (en) Tetrahydropyrrolothiazine compounds
GB201317363D0 (en) Novel compounds
GB201304526D0 (en) New compounds
GB201311891D0 (en) Novel compound
RS57838B1 (en) Arylquinazolines
EP2957205A4 (en) Hand-dryer
GB201311910D0 (en) Novel Compounds
HK1222658A1 (en) Cyanotriazole compounds
EP2956141A4 (en) Novel uses
GB2514689B (en) Quick-Coupler
EP3000028A4 (en) Auto-calendaring

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)